Catheter ablation for AF improves global thrombotic profile and enhances fibrinolysis
File(s)11239_2017_Article_1548.pdf (1.07 MB)
Published version
Author(s)
Type
Journal Article
Abstract
Patients with atrial fibrillation (AF) are at
increased risk of thrombotic events despite oral anticoagulation
(OAC). Radiofrequency catheter ablation (RFCA) can
restore and maintain sinus rhythm (SR) in patients with AF.
To assess whether RFCA improves thrombotic status. 80
patients (71% male, 64±12y) with recently diagnosed AF,
on OAC and scheduled to undergo RFCA or DC cardioversion
(DCCV) were recruited. Thrombotic status was assessed
using the point-of-care global thrombosis test (GTT), before,
and 4–6 weeks after DCCV and 3 months after RFCA. The
GTT first measures the time taken for occlusive thrombus
formation (occlusion time, OT), while the second phase of
the test measures the time taken to spontaneously dissolve
this clot through endogenous thrombolysis (lysis time, LT).
3 months after RFCA, there was a significant reduction in
LT (1994s [1560; 2475] vs. 1477s [1015; 1878]) in those
who maintained SR, but not in those who reverted to AF. At
follow-up, LT was longer in those in AF compared to those
in SR (AF 2966s [2038; 3879] vs. SR 1477s [1015; 1878]).
RFCA resulted in no change in OT value, irrespective of hythm outcome. Similarly, there was no change in OT or
LT in response to DCCV, irrespective of whether SR was
restored. Successful restoration and maintenance of SR following
RFCA of AF is associated with improved global
thrombotic status with enhanced fibrinolysis. Larger studies
are required to confirm these early results and investigate
whether improved thrombotic status translates into fewer
thromboembolic events.
increased risk of thrombotic events despite oral anticoagulation
(OAC). Radiofrequency catheter ablation (RFCA) can
restore and maintain sinus rhythm (SR) in patients with AF.
To assess whether RFCA improves thrombotic status. 80
patients (71% male, 64±12y) with recently diagnosed AF,
on OAC and scheduled to undergo RFCA or DC cardioversion
(DCCV) were recruited. Thrombotic status was assessed
using the point-of-care global thrombosis test (GTT), before,
and 4–6 weeks after DCCV and 3 months after RFCA. The
GTT first measures the time taken for occlusive thrombus
formation (occlusion time, OT), while the second phase of
the test measures the time taken to spontaneously dissolve
this clot through endogenous thrombolysis (lysis time, LT).
3 months after RFCA, there was a significant reduction in
LT (1994s [1560; 2475] vs. 1477s [1015; 1878]) in those
who maintained SR, but not in those who reverted to AF. At
follow-up, LT was longer in those in AF compared to those
in SR (AF 2966s [2038; 3879] vs. SR 1477s [1015; 1878]).
RFCA resulted in no change in OT value, irrespective of hythm outcome. Similarly, there was no change in OT or
LT in response to DCCV, irrespective of whether SR was
restored. Successful restoration and maintenance of SR following
RFCA of AF is associated with improved global
thrombotic status with enhanced fibrinolysis. Larger studies
are required to confirm these early results and investigate
whether improved thrombotic status translates into fewer
thromboembolic events.
Date Issued
2017-11-01
Date Acceptance
2017-09-18
Citation
Journal of Thrombosis and Thrombolysis, 2017, 44 (4), pp.413-426
ISSN
0929-5305
Publisher
Springer Verlag
Start Page
413
End Page
426
Journal / Book Title
Journal of Thrombosis and Thrombolysis
Volume
44
Issue
4
Copyright Statement
© The Author(s) 2017. This article is an open access publication
License URL
Subjects
Science & Technology
Life Sciences & Biomedicine
Hematology
Peripheral Vascular Disease
Cardiovascular System & Cardiology
Atrial fibrillation
Thrombosis
Fibrinolysis
Ablation
Cardioversion
ATRIAL-FIBRILLATION
PLATELET ACTIVATION
END-POINTS
FOLLOW-UP
STROKE
THROMBOGENESIS
INFLAMMATION
MANAGEMENT
RHYTHM
TRIAL
Publication Status
Published